Validation of a continuous infusion of low dose Iohexol to measure glomerular filtration rate: Randomised clinical trial

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Dixon, John J ^a,b   Lane, Katie ^a,b   Dalton, R Neil ^c   Turner, Charles ^c   Grounds, R Michael ^a   MacPhee, Iain A M ^a,b   Philips, Barbara J ^a,b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Acute kidney injury; Glomerular filtration rate; Iohexol; Validation

Indexed keywords

CREATININE; IOHEXOL;

ACCURACY; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; KIDNEY CLEARANCE; LOADING DRUG DOSE; LOW DRUG DOSE; MALE; NORMAL HUMAN; PLASMA CLEARANCE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STEADY STATE; TANDEM MASS SPECTROMETRY; URINE VOLUME; VALIDATION STUDY; DEMOGRAPHY; DOSE RESPONSE; MIDDLE AGED; PHYSIOLOGY; TIME FACTOR;

ADULT; AGED; DEMOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IOHEXOL; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84924308448     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0414-3     Document Type: Article

References (39)

1. Mehta R, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
2. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-12.
3. Kidney Disease Improving Global Outcomes work group. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1):1-138.
4. Ostermann M, Chang RWS. Challenges of defining acute kidney injury. Q J Med. 2011;104:237-43.
5. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol. 2009;20:672-9.
6. Doi K, Yuen PS, Eisner C, Hu X, Leelahavanichkul A, Schnermann J, et al. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol. 2009;20:1217-21.
7. Wilson FP, Sheehan JM, Mariani LH, Berns JS. Creatinine generation is reduced in patients requiring continuous venovenous hemodialysis and independently predicts mortality. Nephrol Dial Transplant. 2012;27:4088-94.
8. Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008;73(9):1008-16.
9. Erley CM, Badar BD, Berger ED, Vochazer A, Jorzik JJ, Dietz K, et al. Plasma clearance of iodine contrast media as a measure of glomerular filtration rate in critically ill patients. Crit Care Med. 2001;29(8):1544-50.
10. Sterner G, Frennby B, Mansson S, Nyman U, Van Western D, Almén T. Determining "true" glomerular filtration rate in healthy adults using infusion of inulin and comparing it with values obtained using other clearance techniques or prediction equations. Scand J Urol Nephrol. 2008;42(3):278-85.
11. Gaspari F, Perico N, Ruggenenti P, Mosconi L, Amuchastegui CS, Guerini E, et al. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol. 1995;6(2):257-63.
12. Effersöe H, Groth S, Jensen LI, Golman K. Measurement of renal function with iohexol. A comparison of iohexol, 99mTc-DTPA and 51Cr-EDTA clearance. Invest Radiol. 1990;25(7):778-82.
13. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). Ann Intern Med. 2009;150(9):604-12.
14. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. 59th WMA General Assembly, Seoul, October 2008. http://www.wma.net/en/30publications/10policies/b3/17c.pdf.
15. European medicines agency. ICH Topic E 6 (R1) Guideline for Good Clinical Practice. http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf.
16. GE Healthcare Inc. OMNIPAQUE (Iohexol): Summary of product characteristics. Princeton, NJ, USA: GE Healthcare. 2009.
17. Hemmegarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006;69(12):2155-61.
18. Mosteller RD. Letters to editor. N Engl J Med. 1987;317(17):1098.
19. Product Information for Agilia MC Injectomat pump. Accessed online via URL http://www.fresenius-kabi.com (accessed 4 November 2010)
20. Brochner-Mortensen J. A simple method for the determination of Glomerular Filtration Rate. Scand J Clin Lab Invest. 1972;30:271-4.
21. Kilbride HS, Stevens PE, Eaglestone G, Knight S, Carter JL, Delaney MP, et al. Accuracy of the MDRD (Modification of diet in Renal Disease) Study and CKD-EPI (CKD Epidemiology Collaboration) Equations for Estimation of GFR in the elderly. Am J Kidney Dis. 2012;61(1):57-66.
22. Shannon JA. The renal excretion of creatinine in man. J Clin Invest. 1935;14(4):403-10.
23. Bland JM, Altman DG. Measuring agreement in medical comparison studies. Stat Methods Med Res. 1999;8:135-60.
24. Fleming JS, Zivanovic MA, Blake GM, Burniston M, Cosgriff PS. Guidelines for the Measurement of Glomerular Filtration Rate using Plasma Sampling. http://www.bnms.org.uk (accessed 23 December 2014).
25. James TJ, Lewis AV, Tan GD, Altmann P, Taylor RP, Levy JC. Validity of simplified protocols to estimate glomerular filtration rate using iohexol clearance. Ann Clin Biochem. 2007;44:369-76.
26. Mills M, Armitage P. The two-period cross-over clinical trial. B J Clin Pharm. 1979;8:7-20.
27. van Acker BAC, Koomen GCM, Arisz L. Drawbacks of the constant-infusion technique for measurement of renal function. Am J Physiol. 1995;268(37):F543-52.
28. Koopman MG, Koomen GCM, Krediet E, de Moor EAM, Hoek FJ, Arisz L. Circadian rhythm of glomerular filtration rate in normal individuals. Clin Sci. 1989;77:105-11.
29. Olsson B, Aulie Å, Sveen K, Andrew E. Human Pharmacokinetics of Iohexol A New Nonionic Contrast Medium. Invest Radiol. 1983;18:177-82.
30. Lundqvist S, Holmberg G, Jakobsson G, Lithner F, Skinningsrud K, Stegmayr B, et al. Assessment of possible nephrotoxicty from Iohexol in patients with normal and impaired renal function. Acta Radiol. 1998;39(4):362-7.
31. Cavalier E, Rozet E, Dubois N, Charlier C, Hubert P, Chapelle J-P, et al. Performance of Iohexol determination in serum and urine by HPLC: validation, risk and uncertainty assessment. Clinica Chem Acta. 2008;396(1-2):80-5.
32. Kays AJ. Economics. In: Biology and Chemistry of Jerusalem Artichoke: Helicanthus tuberosus L. Nottingham, SF: Taylor & Francis Group LLC. 2008. p. 407-21.
33. Nissenson AR, Pereira BJG, Collins AJ, Steinberg EP. Prevalence and characteristics of individuals with chronic kidney disease in a large health organization. Am J Kid Dis. 2001;37(6):1177-83.
34. Schnurr E, Lahme W, Küppers H. Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol. 1980;13:26-9.
35. Moore AEB, Park-Holohan S-J, Blake GM, Fogelman I. Conventional measurements of GFR using Cr-51-EDTA overestimate true renal clearance by 10%. Eur J Nucl Med Mol Imaging. 2003;30:4-8.
36. Barrett BJ, Carlisle EJ. Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology. 1993;188(1):171-8.
37. McDonald RJ, McDonald JS, Bida JP, Carter RE, Fleming CJ, Misra S, et al. Intravenous contrast material-induced nephropathy: causal or coincident phenomenon. Radiol. 2013;267(1):106-18.
38. McDonald JS, McDonald RJ, Comin J, Williamson EE, Katzberg RW, Murad MH, et al. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiol. 2013;267(1):119-28.
39. Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O'Connor GT, et al. Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv. 2010;3(4):346-50.